Kisspeptin 10mg

Description

Kisspeptin 10mg (Kisspeptin-10 or metastin fragment) is a synthetic decapeptide (Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH₂) derived from the KISS1 gene product, acting as a key upstream regulator of the hypothalamic-pituitary-gonadal (HPG) axis. By binding to the kisspeptin receptor (KISS1R/GPR54) on GnRH neurons, Kisspeptin 10mg potently stimulates the release of gonadotropin-releasing hormone (GnRH), which in turn triggers luteinizing hormone (LH) and follicle-stimulating hormone (FSH) secretion from the pituitary gland—leading to increased gonadal steroidogenesis, testosterone production in males, and estrogen/progesterone pathways in females. Research in humans and animals shows Kisspeptin 10mg elicits rapid, dose-dependent increases in LH (often 8–10 IU/L peak or higher) and FSH, with sexual dimorphism observed: robust gonadotropin stimulation in men and during specific menstrual phases in women, alongside potential enhancement of sexual arousal, motivation, and mood via central effects. Clinical studies highlight its promise as a therapeutic target for hypogonadotropic hypogonadism, infertility, delayed puberty, and hypoactive sexual desire disorder (HSDD), with bolus or infusion protocols demonstrating increased LH pulse frequency, testosterone levels, and reversal of suppression in certain models. In research and men’s health contexts, Kisspeptin 10mg (typically supplied as a lyophilized 10mg vial) is reconstituted with bacteriostatic water and administered via subcutaneous injection (research doses often 100–200 mcg or lower per bolus, with protocols varying from single doses to repeated for pulsatile effects) to explore HPG axis dynamics, fertility preservation, natural testosterone support, or libido enhancement without exogenous hormone suppression. While preclinical and early human data suggest benefits like improved gonadal function, mood/behavior regulation, and potential metabolic effects (e.g., in obesity-diabetes models), Kisspeptin 10mg is not FDA-approved for any therapeutic, hormone optimization, fertility, or wellness use as of 2026—it remains an investigational research peptide with limited large-scale human trials beyond specific reproductive studies. Safety appears favorable in short-term research (mild transient effects like flushing or headache), but unknowns include long-term desensitization risks with continuous use, potential for overstimulation, or interactions with other hormones. Always use under strict medical supervision with hormone monitoring (LH, FSH, testosterone, estradiol) and proper aseptic technique for reconstitution/injection. Kisspeptin 10mg should complement—not replace—evidence-based approaches to reproductive health or hormone balance. Consult a healthcare provider for personalized guidance, sourcing from reputable research suppliers, and to ensure suitability within ethical research or clinical frameworks.